Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Nov 27, 2020 12:55pm
142 Views
Post# 31989961

RE:RE:RE:RE:Very strong quarter !!!

RE:RE:RE:RE:Very strong quarter !!!They have limited visibility on revenues because they really don't know their customers as bulk of sales is through distributors, mainly Symrise. They state that sales from Q to Q will be lumpy.

The only indicator is industry market trends, which calls for BG sales to have a CAGR of about 7.5%.


prophetoffacts wrote:

The problem is that CZO has limited visibility concerning what is coming next quarter and quarter-to-quarter sales can be quite volitile. CZO is forced to be conservative and speak of year-over-year results so as not to be hit by the quarter-to-quarter variability.

Looking back at sales over the last decade one can see the year-over-year growth and this is part of the reason Gilles sticks with his 10% growth guidance until proven otherwise. 


<< Previous
Bullboard Posts
Next >>